Corneal cross-linking is effective in treating young keratoconus patients
A clinical trial in 60 keratoconus patients aged 10-16 years old, most of which were based at the NIHR Clinical Research Facility at Moorfields Eye Hospital, found that a treatment for keratoconus, known as corneal cross linking, was effective at stopping its progression in young patients. We shall be hosting a presentation of the results of this trial…